Cargando…

Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms

The major complications of Philadelphia-negative (Ph-Negative) myeloproliferative neoplasms (MPNs) are thrombosis, haemorrhage and leukemic transformation. As systemic and haematological diseases, MPNs have the potential to affect many tissues and organs. Some complications lead to the diagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liisborg, Charlotte, Hasselbalch, Hans Carl, Sørensen, Torben Lykke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139696/
https://www.ncbi.nlm.nih.gov/pubmed/32121664
http://dx.doi.org/10.3390/cancers12030573
_version_ 1783518825683091456
author Liisborg, Charlotte
Hasselbalch, Hans Carl
Sørensen, Torben Lykke
author_facet Liisborg, Charlotte
Hasselbalch, Hans Carl
Sørensen, Torben Lykke
author_sort Liisborg, Charlotte
collection PubMed
description The major complications of Philadelphia-negative (Ph-Negative) myeloproliferative neoplasms (MPNs) are thrombosis, haemorrhage and leukemic transformation. As systemic and haematological diseases, MPNs have the potential to affect many tissues and organs. Some complications lead to the diagnosis of MPNs, but other signs and symptoms are often misdiagnosed or neglected as a sign of MPN disease. Therefore, we reviewed the current literature to investigate and delineate the clinical manifestations seen in the eyes of Ph-negative MPN patients. We found that ocular manifestations are common among patients with MPNs. The most frequently described manifestations are due to the consequences of haematological abnormalities causing microvascular disturbances and hyperviscosity. More serious and vision-threatening complications as thrombotic events in the eyes have been repeatedly reported as well. These ocular symptoms may precede more serious extraocular complications. Accordingly, combined ophthalmological and haematological management have the potential to discover these diseases earlier and prevent morbidity and mortality in these patients. Furthermore, routine ophthalmological screening of all newly diagnosed MPN patients may be a preventive approach for early diagnosis and timely treatment of the ocular manifestations.
format Online
Article
Text
id pubmed-7139696
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71396962020-04-10 Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms Liisborg, Charlotte Hasselbalch, Hans Carl Sørensen, Torben Lykke Cancers (Basel) Review The major complications of Philadelphia-negative (Ph-Negative) myeloproliferative neoplasms (MPNs) are thrombosis, haemorrhage and leukemic transformation. As systemic and haematological diseases, MPNs have the potential to affect many tissues and organs. Some complications lead to the diagnosis of MPNs, but other signs and symptoms are often misdiagnosed or neglected as a sign of MPN disease. Therefore, we reviewed the current literature to investigate and delineate the clinical manifestations seen in the eyes of Ph-negative MPN patients. We found that ocular manifestations are common among patients with MPNs. The most frequently described manifestations are due to the consequences of haematological abnormalities causing microvascular disturbances and hyperviscosity. More serious and vision-threatening complications as thrombotic events in the eyes have been repeatedly reported as well. These ocular symptoms may precede more serious extraocular complications. Accordingly, combined ophthalmological and haematological management have the potential to discover these diseases earlier and prevent morbidity and mortality in these patients. Furthermore, routine ophthalmological screening of all newly diagnosed MPN patients may be a preventive approach for early diagnosis and timely treatment of the ocular manifestations. MDPI 2020-03-02 /pmc/articles/PMC7139696/ /pubmed/32121664 http://dx.doi.org/10.3390/cancers12030573 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Liisborg, Charlotte
Hasselbalch, Hans Carl
Sørensen, Torben Lykke
Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
title Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
title_full Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
title_fullStr Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
title_full_unstemmed Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
title_short Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
title_sort ocular manifestations in patients with philadelphia-negative myeloproliferative neoplasms
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139696/
https://www.ncbi.nlm.nih.gov/pubmed/32121664
http://dx.doi.org/10.3390/cancers12030573
work_keys_str_mv AT liisborgcharlotte ocularmanifestationsinpatientswithphiladelphianegativemyeloproliferativeneoplasms
AT hasselbalchhanscarl ocularmanifestationsinpatientswithphiladelphianegativemyeloproliferativeneoplasms
AT sørensentorbenlykke ocularmanifestationsinpatientswithphiladelphianegativemyeloproliferativeneoplasms